This exec sold his start-up to big pharma. Now he has a bigger goal
In 2022 Manny Simons sold his company to Ely Lilly. Now, as MD for the pharmaceutical giant in Australia and New Zealand, he is fighting to secure a PBS listing.
8 Apr 19:00 · Australian Financial Review